Pre Gestational Thalassemia Screening in Mainland China: The First Two Years of a Preventive Program
暂无分享,去创建一个
C. Liao | Dongzhi Li | Jian Li | Xing-mei Xie | Jian-ying Zhou | F. Jiang | Gui-lan Chen | Jianying Zhou | Xing-Mei Xie
[1] Chi-kong Li. New trend in the epidemiology of thalassaemia. , 2017, Best practice & research. Clinical obstetrics & gynaecology.
[2] D. Canatan,et al. Report on Ten Years’ Experience of Premarital Hemoglobinopathy Screening at a Center in Antalya, Southern Turkey , 2016, Hemoglobin.
[3] Dongzhi Li,et al. Consequences of Delayed Prenatal Diagnosis of β-Thalassemia in Mainland China , 2016, Hemoglobin.
[4] D. Rund. Thalassemia 2016: Modern medicine battles an ancient disease , 2016, American journal of hematology.
[5] Dongzhi Li,et al. Prevention of Hb Bart’s (γ4) Disease Associated with the – –THAI α0-Thalassemia Deletion in Mainland China , 2015, Hemoglobin.
[6] C. Liao,et al. Implementation of Newborn Screening for Hemoglobin H Disease in Mainland China , 2015, Indian Journal of Hematology and Blood Transfusion.
[7] C. Liao,et al. Prenatal control of Hb Bart’s hydrops fetalis: a two-year experience at a mainland Chinese hospital , 2015, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.
[8] Dongzhi Li,et al. Prenatal Control of Hb Bart’s Disease in Mainland China: Can We Do Better? , 2014, Hemoglobin.
[9] Shaoke Chen,et al. Prevention and control of Hb Bart's disease in Guangxi Zhuang Autonomous Region, China. , 2014, European journal of obstetrics, gynecology, and reproductive biology.
[10] C. Liao,et al. Newborn Screening for Hb H Disease by Determination of Hb Bart’s Using the Sebia Capillary Electrophoresis System in Southern China , 2014, Hemoglobin.
[11] Dongzhi Li,et al. Birth of children with severe β‐thalassemia at a tertiary obstetric hospital: what are the reasons behind it? , 2013, Prenatal diagnosis.
[12] P. Grisanti,et al. Carrier screening for inherited haemoglobin disorders among secondary school students and young adults in Latium, Italy , 2013, Journal of Community Genetics.
[13] P. Grisanti,et al. Carrier screening for inherited haemoglobin disorders among secondary school students and young adults in Latium, Italy , 2013, Journal of Community Genetics.
[14] C. Liao,et al. Prenatal control of nondeletional α‐thalassemia: first experience in mainland China , 2013, Prenatal diagnosis.
[15] Dongzhi Li,et al. Newborn screening for α-thalassaemia by a capillary electrophoresis method , 2012, Journal of medical screening.
[16] L. Wadsworth,et al. In Utero Diagnosis and Management of a Fetus With Homozygous &agr;-Thalassemia in the Second Trimester: A Case Report and Literature Review , 2011, Journal of pediatric hematology/oncology.
[17] E. Vichinsky,et al. Heterogeneity of hemoglobin H disease in childhood. , 2011, The New England journal of medicine.
[18] E. Angelucci. Hematopoietic stem cell transplantation in thalassemia. , 2010, Hematology. American Society of Hematology. Education Program.
[19] Maxine Sun,et al. Molecular epidemiological survey of haemoglobinopathies in the Guangxi Zhuang Autonomous Region of southern China , 2010, Clinical genetics.
[20] Lin Peng,et al. Hemoglobin H Disease in Guangxi Province, Southern China: Clinical Review of 357 Patients , 2010, Acta Haematologica.
[21] Dongzhi Li. Premarital screening for thalassemia in mainland China , 2009, Prenatal Diagnosis.
[22] Matthew Darlison,et al. Global epidemiology of haemoglobin disorders and derived service indicators. , 2008, Bulletin of the World Health Organization.
[23] C. Liao,et al. A case of transfusion‐dependent nondeletional Hb H disease undiagnosed during prenatal screening for thalassemia , 2008, Prenatal diagnosis.
[24] Xiang-min Xu,et al. Carrier screening for α‐ and β‐thalassemia in pregnancy: the results of an 11‐year prospective program in Guangzhou Maternal and Neonatal hospital , 2005 .
[25] G. Luo,et al. The prevalence and spectrum of α and β thalassaemia in Guangdong Province: implications for the future health burden and population screening , 2004, Journal of Clinical Pathology.
[26] Y. Lau,et al. Should we screen for globin gene mutations in blood samples with mean corpuscular volume (MCV) greater than 80 fL in areas with a high prevalence of thalassaemia? , 2001, Journal of clinical pathology.
[27] V. Chan,et al. Genetic and clinical features of hemoglobin H disease in Chinese patients. , 2000, The New England journal of medicine.
[28] V. Chan,et al. A reverse dot‐blot method for rapid detection of non‐deletion α thalassaemia , 1999 .
[29] Qiang Zhang,et al. Prenatal diagnosis of β-thalassemia in Guangxi Zhuang Autonomous Region, China , 2013, Archives of Gynecology and Obstetrics.
[30] E. Vichinsky. Alpha thalassemia major--new mutations, intrauterine management, and outcomes. , 2009, Hematology. American Society of Hematology. Education Program.
[31] E. Ma,et al. Interaction between (--SEA) alpha-thalassemia deletion and uncommon non-deletional alpha-globin gene mutations in Chinese patients. , 2001, Haematologica.